Literature DB >> 26265715

Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings.

Matthew Denker1, Suzanne Boyle1, Amanda H Anderson1, Lawrence J Appel1, Jing Chen1, Jeffrey C Fink1, John Flack1, Alan S Go1, Edward Horwitz1, Chi-Yuan Hsu1, John W Kusek1, James P Lash1, Sankar Navaneethan1, Akinlolu O Ojo1, Mahboob Rahman1, Susan P Steigerwalt1, Raymond R Townsend1, Harold I Feldman2.   

Abstract

The Chronic Renal Insufficiency Cohort (CRIC) Study is a United States multicenter, prospective study of racially and ethnically diverse patients with CKD. Although the original aims of the study were to identify novel predictors of CKD progression and to elucidate the risk and manifestations of cardiovascular disease among nearly 4000 individuals with CKD, the CRIC Study has evolved into a national resource for investigation of a broad spectrum of CKD-related topics. The study has produced >90 published scientific articles, promoted many young investigative careers in nephrology, and fostered international collaborations focused on understanding the global burden of CKD. The third phase of the CRIC Study will complete enrollment of 1500 additional study participants in 2015 and is designed to answer questions regarding morbidity and mortality in mild-to-moderate CKD and to assess the burden of CKD in older persons. This review highlights some of the salient findings of the CRIC Study in the areas of race and ethnicity, CKD progression, CKD and cognition, and cardiovascular disease outcomes; it also outlines the ongoing and forthcoming opportunities for the global nephrology community to enhance its understanding of CKD and related complications through the study.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; chronic renal insufficiency; cohort study

Mesh:

Year:  2015        PMID: 26265715      PMCID: PMC4633788          DOI: 10.2215/CJN.04260415

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  48 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

3.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

4.  Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Edgard Wehbe; Rupesh Raina; James F Simon; Titte R Srinivas; Anil Jain; Martin J Schreiber; Joseph V Nally
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

5.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications.

Authors:  Chi-yuan Hsu; Kathleen Propert; Dawei Xie; Lee Hamm; Jiang He; Edgar Miller; Akinlolu Ojo; Michael Shlipak; Valerie Teal; Raymond Townsend; Matthew Weir; Jillian Wilson; Harold Feldman
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

6.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Authors:  Tamara Isakova; Huiliang Xie; Wei Yang; Dawei Xie; Amanda Hyre Anderson; Julia Scialla; Patricia Wahl; Orlando M Gutiérrez; Susan Steigerwalt; Jiang He; Stanley Schwartz; Joan Lo; Akinlolu Ojo; James Sondheimer; Chi-yuan Hsu; James Lash; Mary Leonard; John W Kusek; Harold I Feldman; Myles Wolf
Journal:  JAMA       Date:  2011-06-15       Impact factor: 56.272

7.  Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.

Authors:  Julia J Scialla; Mary B Leonard; Raymond R Townsend; Lawrence Appel; Myles Wolf; Matt J Budoff; Jing Chen; Eva Lustigova; Crystal A Gadegbeku; Melanie Glenn; Asaf Hanish; Dominic Raj; Sylvia E Rosas; Stephen L Seliger; Matthew R Weir; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

8.  Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Matthew J Budoff; Daniel J Rader; Muredach P Reilly; Emile R Mohler; Jim Lash; Wei Yang; Leigh Rosen; Melanie Glenn; Valerie Teal; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2011-07-23       Impact factor: 8.860

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

10.  Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.

Authors:  Stefan Kiechl; Georg Schett; Gregor Wenning; Kurt Redlich; Martin Oberhollenzer; Agnes Mayr; Peter Santer; Josef Smolen; Werner Poewe; Johann Willeit
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

View more
  36 in total

1.  Sex-Related Disparities in CKD Progression.

Authors:  Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2018-12-03       Impact factor: 10.121

Review 2.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

3.  Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Authors:  Sushrut S Waikar; Venkata Sabbisetti; Johan Ärnlöv; Axel C Carlsson; Josef Coresh; Harold I Feldman; Meredith C Foster; Gudeta D Fufaa; Johanna Helmersson-Karlqvist; Chi-Yuan Hsu; Paul L Kimmel; Anders Larsson; Yumin Liu; Lars Lind; Kathleen D Liu; Theodore E Mifflin; Robert G Nelson; Ulf Risérus; Ramachandran S Vasan; Dawei Xie; Xiaoming Zhang; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2016-06-07       Impact factor: 5.992

Review 4.  Statistical Methods for Recurrent Event Analysis in Cohort Studies of CKD.

Authors:  Wei Yang; Christopher Jepson; Dawei Xie; Jason A Roy; Haochang Shou; Jesse Yenchih Hsu; Amanda Hyre Anderson; J Richard Landis; Jiang He; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-17       Impact factor: 8.237

5.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

6.  Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.

Authors:  Anand Srivastava; Arnaud D Kaze; Ciaran J McMullan; Tamara Isakova; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2017-11-11       Impact factor: 8.860

7.  Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Brian Kwan; Tobias Fuhrer; Jing Zhang; Manjula Darshi; Benjamin Van Espen; Daniel Montemayor; Ian H de Boer; Mirela Dobre; Chi-Yuan Hsu; Tanika N Kelly; Dominic S Raj; Panduranga S Rao; Santosh L Saraf; Julia Scialla; Sushrut S Waikar; Kumar Sharma; Loki Natarajan
Journal:  Am J Kidney Dis       Date:  2020-05-05       Impact factor: 8.860

Review 8.  Statistical Methods for Modeling Time-Updated Exposures in Cohort Studies of Chronic Kidney Disease.

Authors:  Dawei Xie; Wei Yang; Christopher Jepson; Jason Roy; Jesse Y Hsu; Haochang Shou; Amanda H Anderson; J Richard Landis; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-17       Impact factor: 8.237

Review 9.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

Review 10.  The global burden of chronic kidney disease: estimates, variability and pitfalls.

Authors:  Richard J Glassock; David G Warnock; Pierre Delanaye
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.